Adaptive Biotechnologies Cash from Financing (TTM) Analysis

Adaptive Biotechnologies Corp (ADPT)

2.91 -0.10 (-3.32%) USD | NASDAQ | Apr 15, 16:00

2.915 0.00 (0.00%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2018. Upgrade now.

Date	Value
December 31, 2023	2.245M
September 30, 2023	2.164M
June 30, 2023	127.67M
March 31, 2023	130.19M
December 31, 2022	132.26M
September 30, 2022	135.54M
June 30, 2022	12.94M
March 31, 2022	15.28M
December 31, 2021	27.15M
September 30, 2021	30.12M
June 30, 2021	303.23M

Date	Value
March 31, 2021	303.24M
December 31, 2020	293.59M
September 30, 2020	289.08M
June 30, 2020	332.59M
March 31, 2020	324.75M
December 31, 2019	319.92M
September 30, 2019	318.45M
June 30, 2019	-1.045M
March 31, 2019	0.905M
December 31, 2018	1.248M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-1.045M

Minimum

Jun 2019

332.59M

Maximum

Jun 2020

163.12M

Average

132.26M

Median

Dec 2022

Cash from Financing (TTM) Benchmarks